Clinical trial
The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics
Recruiting now · Not applicable · 1 countries · Registry ID NCT05791604
What this study is about
Prader-Willi syndrome (PWS) is a rare genetic disease, with hyperappetite and severe obesity. At present, there is no effective drugs and interventions to help control the appetite of PWS patients. More and more evidence has shown that gut microbiota is closely related to obesity. Probiotics and prebiotics can improve the structure of gut microbiota, thus improve blood lipid levels and other biochemical indicators of obese people. Therefore, this study intends to explore the effectiveness and safety of probiotics and prebiotics in controlling appetite and weight gain of PWS children.
Basic eligibility
Full registry criteria
Treatments and study arms
probiotics including B. lactis B420, B. lactis HN019, B. animalis Bb-12, L. rhamnosus GG
Take probiotics, 2g each time, twice a day, for 12 weeks
Prebiotics with galactomannan and oligofructose
Take probiotics, 2g each time, twice a day, for 12 weeks Take prebiotics, 25g each time, twice a day, for 12 weeks
Primary outcomes
Body mass index is calculated as weight (kg)/\[Height (m)\^2\]. Weight and height will be combined to report BMI in kg/m\^2.
Study locations
1 locations were listed when this page was built. The first 40 are shown.